These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22123566)

  • 1. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
    Amine K; Atouk A; Moussamih S; Saile R; Mikou A; Kettani A
    Ann Biol Clin (Paris); 2011; 69(6):671-7. PubMed ID: 22123566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
    Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
    Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
    Sharma R; Singh B; Mahajan M
    Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].
    Chotkowska E; Kurjata P; Kupść W
    Pol Merkur Lekarski; 2001 Oct; 11(64):348-51. PubMed ID: 11770317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid and lipoprotein profile abnormality in predicting the risk of coronary artery disease in non-diabetic patients attending NMCTH, Birgunj.
    Adak M; Shivapuri JN
    Nepal Med Coll J; 2010 Sep; 12(3):158-64. PubMed ID: 21446364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
    Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
    Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.